Marissa Natelson Love

Marissa Natelson Love

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Clinics in Geriatric Medicine
Verified
Journal Article
Closed access
CHCaroline N. Harada
Caroline N. Harada
MLMarissa Natelson Love
Marissa Natelson Love
KTKristen L. Triebel
Kristen L. Triebel

13 December 2019 in Cold Spring Harbor Molecular Case Studies
Verified
Journal Article
Open access
PDF file
JCJ. Nicholas Cochran
J. Nicholas Cochran
EMEmily C. McKinley
Emily C. McKinley
MCMeagan Cochran
Meagan Cochran
MAMichelle D. Amaral
Michelle D. Amaral
BMBryan A. Moyers
Bryan A. Moyers
ERErik D. Roberson
Erik D. Roberson
We assessed the results of genome sequencing for early-onset dementia. Participants were selected from a memory disorders clinic. Genome sequencing was performed along with C9orf72 repeat expansion testing. All returned sequencing results were Sanger-validated. Prior clinical diagnoses included Alzheimer's disease, frontotemporal dementia, and unspecified dementia. The mean age of onset was 54 (41–76). Fifty percent of patients had a strong family history, 37.5% had some, and 12.5% had no known family history. Nine of 32 patients (28%) had a variant defined as pathogenic or likely pathogenic (P/LP) by American College of Medical Genetics and Genomics standards, including variants in APP, C9orf72, CSF1R, and MAPT. Nine patients (including three with P/LP variants) harbored established risk alleles with moderate penetrance (odds ratios of ∼2–5) in ABCA7, AKAP9, GBA, PLD3, SORL1, and TREM2. All six patients harboring these moderate penetrance variants but not P/LP variants also had one or two APOE ε4 alleles. One patient had two APOE ε4 alleles with no other established contributors. In total, 16 patients (50%) harbored one or more genetic variants likely to explain symptoms. We identified variants of uncertain significance (VUSs) in ABI3, ADAM10, ARSA, GRID2IP, MME, NOTCH3, PLCD1, PSEN1, TM2D3, TNK1, TTC3, and VPS13C, also often along with other variants. In summary, genome sequencing for early-onset dementia frequently identified multiple established or possible contributory alleles. These observations add support for an oligogenic model for early-onset dementia.

28 May 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
RGRahul R. Gaini
Rahul R. Gaini
KPKush M. Patel
Kush M. Patel
SKSaad A. Khan
Saad A. Khan
NSNikhi Singh
Nikhi Singh
MLMarissa Natelson Love
Marissa Natelson Love

1 January 2016 in Medical & Clinical Reviews
Verified
Journal Article
Open access
PDF file
MLMarissa Natelson Love
Marissa Natelson Love
GRGabrielle Ruff
Gabrielle Ruff
DGDavid S Geldmacher
David S Geldmacher
Title: Social Cognition in Older Adults: A Review of Neuropsychology, Neurobiology, and Functional Connectivity. Background: Social cognition is an understudied area in cognitive aging. A Medline search using the term “social cognition” and limited to “Aged:65+ years” resulted in only 20 English language references. Methods and Findings: From these references, and review of additional citations from their reference lists, it appears that older adult’s ability to correctly identify another person’s state of mind is reduced, but their ability to perceive emotion remains more intact. These deficits may correlate with established areas of agerelated cortical and white matter volume loss in the prefrontal cortex and temporal insula, respectively. Additionally, changes in cerebral functional connectivity with age may contribute to these observations. Conclusions: This review briefly outlines the neuropsychological, neuroanatomical and functional connectivity literature regarding social cognition in normal cognitive aging. Additionally, we discuss the potential functional implications of age-related changes in social cognition.

12 June 2023 in Cold Spring Harbor Molecular Case Studies
Verified
Journal Article
Open access
PDF file
CWCarter A. Wright
Carter A. Wright
JTJared Taylor
Jared Taylor
MCMeagan Cochran
Meagan Cochran
JLJames M. J. Lawlor
James M. J. Lawlor
BMBelle A. Moyers
Belle A. Moyers
JCJesse Nicholas Cochran
Jesse Nicholas Cochran
We collected and analyzed genomic sequencing data from individuals with clinician-diagnosed early-onset or atypical dementia. Thirty-two patients were previously described, with 68 newly described in this report. Of those 68, 62 patients self-reported white, non-Hispanic ethnicity and 6 reported as African–American, non-Hispanic. Fifty-three percent of patients had a returnable variant. Five patients harbored a pathogenic variant as defined by the American College of Medical Genetics criteria for pathogenicity. A polygenic risk score (PRS) was calculated for Alzheimer's patients in the total cohort and compared to the scores of a late-onset Alzheimer's cohort and a control set. Patients with early-onset Alzheimer's had higher non-APOEPRSs than patients with late-onset Alzheimer's, supporting the conclusion that both rare and common genetic variation associate with early-onset neurodegenerative disease risk.

28 August 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJ. Nicholas Cochran
J. Nicholas Cochran
EMEmily C. McKinley
Emily C. McKinley
MCMeagan Cochran
Meagan Cochran
MAMichelle D. Amaral
Michelle D. Amaral
BMBryan A. Moyers
Bryan A. Moyers
ERErik D. Roberson
Erik D. Roberson
We assessed the utility of genome sequencing for early-onset dementia. Participants were selected from a memory disorders clinic. Genome sequencing was performed along with C9orf72 repeat expansion testing. All returned sequencing results were Sanger validated clinically. Prior clinical diagnoses included Alzheimer’s disease, frontotemporal dementia, and unspecified dementia. The mean age-of-onset was 54 (41–76). 50% of patients had a strong family history, 37.5% had some, and 12.5% had no known family history. Nine of 32 patients (28%) had a variant defined as pathogenic or likely pathogenic (P/LP) by American College of Medical Genetics standards, including variants in APP , C9orf72 , CSF1R , and MAPT . Nine patients (including three with P/LP variants) harbored established risk alleles with moderate penetrance (odds ratios of about 2–5) in ABCA7 , AKAP9 , GBA , PLD3 , SORL1 , and TREM2 . All six patients harboring these moderate penetrance variants but not P/LP variants also had one or two APOE ε4 alleles. One patient had two APOE ε4 alleles with no other established contributors. In total, 16 patients (50%) harbored one or more genetic variants likely to explain symptoms. We identified variants of uncertain significance (VUSs) in ABI3, ADAM10, ARSA, GRID2IP, MME, NOTCH3, PLCD1, PSEN1, TM2D3, TNK1, TTC3, and VPS13C , also often along with other variants. In summary, genome sequencing for early-onset dementia demonstrated high utility, with particular advantages where targeted testing may fail such as atypical variant-disease associations or presence of multiple moderate impact alleles. One or more established contributory alleles is often present in early-onset dementia, supporting an oligogenic model.